Jasper Therapeutics Inc.

JSPR | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.62

+$0.02 (+2.87%)

Sep 22, 2026, 4:00 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $9.8M

Enterprise Value $2.75M

Beta 3.04

Average Volume 1.15M

Shares Outstanding (Diluted) 28.7M

Shares Change YoY 87.15%

Institutional Ownership 55.15%

Exchange NASDAQ

ISIN US4718712023

Price Performance

Price Change 1M -14.3%

Price Change 3M 22.7%

Price Change 6M -45.0%

Price Change YTD -67.4%

Price Change 1Y -76.4%

Price Change 3Y -92.3%

Price Change 5Y -99.6%

1M CAGR (ann.) -15.1%

1Y CAGR (ann.) -76.7%

5Y CAGR (ann.) -64.0%

All-Time CAGR -53.2%

Valuation

PE Ratio -0.38

Forward PE N/A

PEG Ratio -0.00

Forward PEG -0.04

PS Ratio N/A

Forward PS 56.40

PB Ratio 6.93

P/FCF Ratio -0.16

P/Adj. FCF Ratio -0.15

P/OCF Ratio -0.29

EV/Sales N/A

EV/EBIT -0.09

EV/EBITDA -0.09

EV/FCF -0.05

Earnings Yield -265.0%

FCF Yield -615.9%

Adj. FCF Yield -655.2%

Financial Health

Net Cash $7.04M

Total Debt $270K

Cash & Short-Term Investments $7.31M

Total Assets $11.8M

Current Ratio 1.47

Quick Ratio 1.47

Debt / Equity Ratio 0.19

Debt / EBITDA -0.01

Debt / FCF -0.00

OCF / Debt -223.46

Interest Coverage 0.00

Altman Z-Score -45.97

Piotroski F-Score 0

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -6.4%

Returns

Return on Assets -269.2%

Return on Equity -618.9%

Return on Invested Capital -1305.0%

Return on Capital Employed -1394.1%

Return on Tangible Assets -269.2%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y 41.5%

EPS CAGR 5Y 49.5%

EPS CAGR 10Y N/A

FCF CAGR 3Y -3.2%

FCF CAGR 5Y -5.0%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 13

EPS Growth Next 3Y 8.6%

Revenue Growth Next 3Y N/A

Earnings Date Nov 8, 2026

EPS Estimate (next Q) -$0.08

EPS Growth Est (next Q) -92.9%

Revenue Est (next Q) $12M

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $2.50

Price Target Upside 316.7%

Cash Flow

Operating Cash Flow $-60.33M

Free Cash Flow $-60.33M

Adj. Free Cash Flow $-64.18M

FCF Per Share -$2.10

OCF Per Share -$2.10

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-21K

Operating Income $-55.16M

EBITDA $-31.23M

Net Income $-31.77M

EPS (Diluted) -$1.59

Revenue / Employee N/A

Profit / Employee $-1.44M

Employees 22